The invention relates to the field of biotechnology and medicine. The invention specifically relates to a compound comprising a liposome covered or decorated at least with the extracellular domain of the APO2L/TRAIL protein, and to the use thereof for developing a medicament preferably for the treatment of a cancer or inflammatory or autoimmune diseases, such as rheumatoid arthritis.
本发明涉及
生物技术和医药领域。本发明具体涉及一种化合物,该化合物由至少覆盖或装饰有 APO2L/
TRAIL 蛋白胞外结构域的脂质体组成,并涉及使用该化合物开发药物,最好用于治疗癌症或炎症性或自身免疫性疾病,如类风湿性关节炎。